PROCESSING DEFICIENT PROGEROID LAMINOPATHIES

Zydus’ biopharma arm acquires global proprietary rights for Progeria treatment

Progeria, which encompasses Hutchinson-Gilford Progeria Syndrome (HGPS) and Processing-Deficient Progeroid Laminopathies (PDPL), are ultra-rare, fatal, genetic premature aging diseases that accelerate mortality in young patients.